August 2020
-
Telehealth: Bridging the Digital Divide Is Still a Work In Progress
By Sandip Pravin Patel, MD, and Martin Edelman, MD Posted: August 21, 2020 Dr. Sandip Pravin Patel Dr. Martin Edelman […]
-
Anne-Marie Baird, BSc, PhD
Posted: August 21, 2020 In addition to her role as a senior research fellow in Trinity College Dublin, Anne-Marie Baird, BSc, PhD, has been elected as the new president of […]
-
An Early Look at Adjuvant Osimertinib Shows a Dramatic Improvement in Disease-Free Survival
By Mary Jo Fidler, MD Posted: August 21, 2020 At the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program Plenary Session, an early look at data from the […]
-
Expanding Efforts Help Address Disparities in Lung Cancer Care
By Kara Nyberg, PhD Posted: August 21, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […]
-
Sustained Funding Vital for Smoking-Cessation Efforts
By Leah K. LawrencePosted: August 21, 2020 In July 2019, England’s government announced its goal to make the country “smoke free” by 2030.1 That may be easier said than done, […]
-
Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration of Smoking Cessation and Lung Cancer Screening
By Lawson Eng, MD, FRCPC, and William K. Evans, MD, FRCPC Posted: August 21, 2020 IN REFERENCE TO: Cao P, Jeon J, Levy DT, et al. Potential impact of cessation […]
-
Patient Perspectives on Telehealth During COVID-19: Balancing Fear, Self-Advocacy
By Jennifer Byrne Posted: August 21, 2020 For nearly 2 decades, Bonnie Anderson has defied incredible odds in the face of mesothelioma, hairy cell leukemia, breast cancer, lung cancer, and […]
-
Conducting a Lung Multidisciplinary Tumor Board at the National University Cancer Institute, Singapore
By Ross Soo, MB, BS, PhD, FRACP Posted: August 21, 2020 Dr. Ross Soo Impressive progress has been achieved in many aspects of lung cancer. Over the past […]
-
Bringing Telehealth to the Front Lines of Lung Cancer Care in the COVID-19 Pandemic
By Luis E. Raez, MD, FACP, FCCP Posted: August 21, 2020 Our current electronic medical records (EMR) are equipped with telehealth capability. Some of us have spent the last 2 […]
-
Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication
By Erik MacLaren, PhD Posted: August 21, 2020 The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Merck’s immune checkpoint inhibitor pembrolizumab, adding a new tissue-agnostic indication […]
View ILCN Archives
Provider Resources